A prospective randomised controlled trial on the use of BMP-7 (OP-1) [eptotermin alfa] and demineralised bone matrix in tibial non-union.
Phase of Trial: Phase IV
Latest Information Update: 10 Jul 2012
At a glance
- Drugs Eptotermin alfa (Primary)
- Indications Non-union fracture
- Focus Therapeutic Use
- 10 Jul 2012 Planned end date changed from 1 Dec 2011 to 1 Jul 2012 as reported by ClinicalTrials.gov.
- 10 Jul 2012 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 03 Jan 2012 Planned end date changed from 1 Nov 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.